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How to assess and manage frailty in HIV patients 
Levett T, Wright J 
As a result of the successful treatment of HIV over the last four decades, people living with HIV 
(PLWH) can now expect a near normal life expectancy1. This change in demographic alongside later 
life acquisition of HIV2, has resulted in clinical services now seeing an older HIV cohort, with patients 
experiencing many of the problems of an older HIV-negative cohort such as multiple medical 




An example case:  
Mr X, age 70 with ‘well-controlled’ chronic HIV infection, presents to his routine HIV clinic appointment 
complaining of recurrent falls, fatigue, low mood, self-reported memory concerns, episodes of urinary 
incontinence and increased difficulty looking after himself at home. 
HIV background:  
 Diagnosed in 1995, aged 48 years. 
 Initial CD4 count 45 cells/mm3  
 Late presentation with Pneumocystis jiroveci pneumonia, defining AIDS. 
 Started antiretroviral drugs (ARVs) 1995 
 Current CD4 556 cells/mm3, viral load (VL) undetectable.  
Past Medical History: 
 Ischaemic Heart Disease 
 Type 2 Diabetes mellitus 
 Hypertension 
 Peripheral neuropathy 
 Depression 
 Benign Prostatic Hypertrophy and bladder instability 
Drug history: 
 Diltiazem 180mg OD 
 Bendroflumethiazide 2.5mg OD 
 Gabapentin 900mg tds 
 Metformin MR 1g OD 
 Mirtazepine 45mg OD  
 Isosorbide mononitrate 20mg BD 
 Aspirin 75mg OD 
 Ramipril 10mg OD 
 Solifenacin 5mg OD  
 Tamsulosin 400mcg OD  
ARV exposure: 





Despite good HIV control, this patient has a complex medical background, with polypharmacy, 
uncontrolled comorbidities and presentations representing frailty syndromes, namely falls, 
continence issues, and both cognitive and functional decline. In the management of complex older 
adults, the next step is a comprehensive geriatric assessment (CGA) to investigate potential causes 
of his symptoms, including the impact of possible psychiatric diagnoses, the aetiology and relevance 
of drug interactions, and to consider referral to appropriate multidisciplinary team (MDT) members. 
In this case, the falls were in part due to postural hypotension, prompting discontinuation of 
bendroflumethiazide, additionally aiding his urinary symptoms. Poorly controlled diabetes was 
causing polyuria and was optimised by adding gliclazide. A cognitive screen, implied impairment and 
he was referred for formal memory assessment, as well to physiotherapy for strength and balance 
training. As a result, his falls frequency reduced, urinary symptoms improved and he remains living 
at home with a once daily care package, with improvements seen in both mood and cognition. 
Frailty is a term frequently used in clinical assessments to describe patients at risk of decline in 
health or function. Patients with frailty are vulnerable to external stressors as they have limited 
reserve, such that a relatively common problem i.e. respiratory tract infection could cause a 
significant event such as a fall, episode of delirium, hospitalisation or even death3. The concept of 
frailty is generally understood but there remains considerable heterogeneity in how clinicians define, 
investigate and manage those with frailty within their practice.  The lack of consensus regarding the 
definition of frailty hampers both the development of a gold-standard diagnostic tool and an 
evidence-based approach to the care of patients with frailty.  
Two main schools of thought predominate the literature: The frailty phenotype4 and the frailty index 
(FI)5. Fried et al. used data from the Cardiovascular Health Study to develop the frailty phenotype; an 
assessment based on the presence of five criteria: unintentional weight loss, exhaustion, weakness, 
low physical activity and slowed walking speed4. Patients are considered frail if they possess three of 
the five criteria, those with one/two classified as ‘pre-frail’ and those without deficit deemed robust. 
Baseline frailty status predicted adverse patient outcomes such as falls, hospitalisation and death4. 
This model is the most frequently utilised tool in frailty research6, especially in the context of HIV7. 
However, it has been challenged, as being less practical to apply in clinical settings and criticised for 
its uni-dimensional nature that focuses mainly on muscle strength and function, neglecting 
psychological and social factors which are known to impact on frailty3,8.  
Rockwood et al. propose the FI, a multi-dimensional approach where ‘deficits’ accumulate across 
functional, cognitive and physical domains with age5. A greater number of deficits confers a greater 
degree of frailty, with a score of 0.25 (e.g. representing 10 of 40 deficits) often taken as the 
threshold for frailty5. The FI may be preferential as its continuous scoring fits with the theory of 
declining physiological reserve, alongside the association between increasing FI and adverse 
outcomes5. Criticisms focus on the large number of items required to create and therefore 
operationalise an index in the clinical environment, though the use of electronic systems may 
overcome this9. Clarity on when to intervene and focus health interventions to attempt to improve 
patients’ reserve is lacking.  
A plethora of alternative frailty screening tools have appeared in the literature based on differing 
patient populations, which mainly take the rule-based criterion approach but differing in their 
chosen frailty predictors. Debate persists as to what should be included in such a screening tool, 
particularly on the role of psychosocial and cognitive factors. Frailty is being increasingly used to 
direct care of older patients with many clinical specialties using these tools to assess risk of decline 
following an adverse event or treatment, such as an operation. It should be recognised that frailty is 
a dynamic process and although there is no cure for frailty there may be components amenable to 
treatment or optimisation3. 
The British Geriatric Society (BGS) ‘Fit for Frailty’ document reports best practice guidance for 
frailty10. Aimed at outpatient and community settings it recommends any interaction with an older 
person as part of health or social care is an opportunity to asses for frailty10.  It recommends that 
frailty is recognised and treated as a long term condition and where present, a holistic assessment 
should result in a comprehensive care and support plan to avoid episodic acute deteriorations which 
often result in hospital admissions10. 
In Brighton, 30% of HIV service users are aged over 50. This, combined with an increasing clinical 
complexity prompted the establishment of a specialised clinic for the management of older PLWH 
exhibiting frailty syndromes. The clinical team comprises an HIV physician, geriatrician, HIV specialist 
nurse and an HIV pharmacist. In keeping with BGS guidelines patients are screened for frailty 
syndromes and then referred internally from the patient’s HIV clinician to the dedicated ‘Silver’ clinic 
for comprehensive assessment and patient-centred management.  
Indications for referral/screen for frailty syndromes: 
 Patients over 50 years  
 Multiple comorbidities 
 Polypharmacy 
 Functional or mobility decline 
Clinical assessment and priorities:  
 Management of polypharmacy, considering drug interactions and adverse effects, facilitated 
through pre-clinic MDT discussion, including an HIV pharmacist. 
 Optimising the management of comorbidities. 
 Identifying social and psychological problems. 
 Formulating health interventions including exercise programmes and peer support groups. 
 Individualised care as appropriate to patients needs and wishes with access to respite and 
HIV palliative care services 
All treatment plans are copied to the referring HIV consultant and, with consent, to the patient’s GP 
with referral to MDT services made through the standard referral pathways for non-HIV older 
patients in Brighton. 
A Brighton based team conducted an online survey of UK HIV services to investigate the current 
provision of and perceived need for dedicated ageing services for PLWH11. Of 102 services surveyed, 
5 had an HIV-physician with an interest in ageing and only 2 reported a specific clinic aimed at older 
patients. 23% reported a perceived need for ageing services, however inadequate patient population 
and satisfaction with existing external services were stated as the main reasons against dedicated 
clinics. Two thirds are deferring complex issues to GPs, meaning a third are using secondary care 
services directly to meet this need. 70% of respondents felt that enhanced BHIVA guidance around 
investigating and monitoring older adults was necessary11. This is a new and expanding area but 
there is currently little evidence as to which model improves outcomes. 
We have also undertaken a year long prospective observational study recruiting PLWH aged ≥50 
from five clinics across Sussex12. Frailty was defined by a modified Fried frailty phenotype and 
potential predictors of frailty were evaluated from collected demographic, clinical, psychosocial and 
functional parameters.  253 participants were recruited (90.9% male), with median age of 59.6 
years. 48/253 met frailty criteria, giving a prevalence of 19% (95% CI 14.6-24.3) A further 111/253 
(43.9%) were pre-frail 94/253 (37.1%) robust. The interesting finding from this cohort was that 
symptoms of low mood, number of co-morbidities and increasing number of non-HIV medications 
were better predictors of frailty than age or HIV-specific factors such as duration of HIV or immune 
parameters12.  
Our data confirms that frailty is an important consideration in older PLWH and our survey highlights 
a perceived need to increase specialist services in some areas to meet these demands. The Brighton 
demographic has a higher older proportion, predominantly MSM, with reasonably low ethnic mix 
and female representation, therefore our model needs to be investigated in other centres, but our 
principles remain in keeping with The BGS ‘Fit for Frailty’ document10.  
Conclusion: 
In managing older PLWH it is increasingly frailty syndromes that are the priorities of care.  A service 
that screens for frailty identifiers will help distinguish which patients require further multidisciplinary 
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